A comparison between platelet aggregation and atp secretion induced by collagen and by paf acether and their inhibition by phenylbutazone, sulphinpyrazone and its metabolites
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 31 (4) , 577-589
- https://doi.org/10.1016/0049-3848(83)90455-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mechanisms of action of sulphinpyrazoneThrombosis Research, 1983
- Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pigEuropean Journal of Pharmacology, 1982
- Clinical Pharmacokinetics and Potentially Important Drug Interactions of SulphinpyrazoneClinical Pharmacokinetics, 1982
- Sulphinpyrazone metabolism during long-term therapy.Published by Wiley ,1981
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Role of Prostaglandin Synthesis in Rabbit Platelet Activation Induced by Basophil-Derived Platelet-Activating FactorThe Journal of Immunology, 1978
- Synthesis of thromboxane B2 and prostaglandins by bovine gastric mucosal microsomesProstaglandins, 1977
- EFFECTS OF SULFINPYRAZONE ON PLATELET PROSTAGLANDIN SYNTHESIS AND PLATELET-RELEASE OF SEROTONIN1977
- GUY'S HOSPITAL.The Lancet, 1823